AK

Arun Kumar Gupta

Active Director Director DIN 01795236
DIN 01795236 First appointment Mar 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2006
Shareholding value •••• Premium profile

About Arun Kumar Gupta

Data last updated:

Arun Kumar Gupta is a Director at Solitaire Biotech Pvt Ltd (since 2006). The company operates in Pharma. Solitaire Biotech Pvt Ltd reported revenue of ₹1.06 Cr (FY 2024).

DIN 01795236
Primary Designation Director
Industry Pharma
First Appointment 08 Mar 2006
Oldest Company Age 20 yrs
Largest company Solitaire Biotech Pvt Ltd · ₹1.06 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Solitaire Biotech Pvt Ltd U24231CH2006PTC029857
Director08 Mar 20062006₹1.06 Cr (FY 2024)Active

Board colleagues of Arun Kumar Gupta

NameDINCompanyDesignation
Savitri Gupta01795223Solitaire Biotech Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Solitaire Biotech Pvt Ltd
Premium access

Shareholding and investment profile for Arun Kumar Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Kumar Gupta

Arun Kumar Gupta currently holds 1 directorship: Solitaire Biotech Pvt Ltd (Director, since 08 Mar 2006, revenue ₹1.06 Cr (FY 2024)).

Arun Kumar Gupta was first appointed on 08 Mar 2006 as Director at Solitaire Biotech Pvt Ltd.

The current boards of Arun Kumar Gupta's companies include Savitri Gupta (Solitaire Biotech Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available